clofarabine (Clolar)
Jump to navigation
Jump to search
Introduction
Tradename: Clolar (FDA-approved in 2004)
Indications
- pediatric acute lymphoblastic leukemia, relapsed or refractory periods
Notes
Manufacturer: Genzyme
More general terms
References
- ↑ Prescriber's Letter 12(2): 2005 New Drugs Approved by the FDA in 2004 Detail-Document#: http://prescribersletter.com/(5bhgn1a4ni4cyp2tvybwfh55)/pl/ArticleDD.aspx?li=1&st=1&cs=&s=PRL&pt=3&fpt=25&dd=210216&pb=PRL (subscription needed) http://www.prescribersletter.com